Kiniksa Pharmaceuticals（纳斯达克代码：KNSA）报告季度每股亏损$(0.12)，低于分析师一致预期的$0.04，下降了400%。去年同期每股收益为$0.35，同比下降了134.29%。公司报告季度销售额为$1.2254亿，未达到分析师一致预期的$1.2338亿，同比下降了0.68%。去年同期销售额为$8339万，同比增长了46.93%。

以上内容来自Benzinga Earnings专栏，原文如下：

Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $0.04 by 400 percent. This is a 134.29 percent decrease over earnings of $0.35 per share from the same period last year. The company reported quarterly sales of $122.54 million which missed the analyst consensus estimate of $123.38 million by 0.68 percent. This is a 46.93 percent increase over sales of $83.39 million the same period last year.